Workflow
Bit Digital(BTBT) - 2024 Q3 - Earnings Call Transcript
2024-11-18 22:24
Bit Digital, Inc. (NASDAQ:BTBT) Q3 2024 Earnings Conference Call November 18, 2024 10:00 AM ET Company Participants Cameron Schnier - Head of IR Sam Tabar - CEO Erke Huang - CFO Billy Krassakopoulos - CEO, Enovum Conference Call Participants Mike Grondahl - Northland Kevin Dede - H.C. Wainwright & Co. Brian Dobson - Clear Street Joshua Zoepfel - Noble Capital Operator Hello, and welcome to the Bit Digital Third Quarter 2024 Earnings Conference Call. Good morning, good afternoon, and good evening depending o ...
Magic Software Enterprises(MGIC) - 2024 Q3 - Earnings Call Transcript
2024-11-18 17:57
Magic Software Enterprises Ltd. (NASDAQ:MGIC) Q3 2024 Earnings Conference Call November 18, 2024 9:30 AM ET Company Participants Asaf Berenstin - CFO Guy Bernstein - CEO Conference Call Participants Tavy Rosner - Barclays Kate Kronstein - William Blair Operator Ladies and gentlemen, thank you for standing by. Welcome to the Magic Software Enterprise 2024 Third Quarter Financial Results Conference Call. Magic's third quarter 2024 earnings release was issued before the market opened this morning, and it has b ...
C3is (CISS) - 2024 Q3 - Earnings Call Transcript
2024-11-18 17:51
C3is Inc. (NASDAQ:CISS) Q3 2024 Earnings Conference Call November 18, 2024 11:00 AM ET Company Participants Diamantis Andriotis - Chief Executive Officer Nina Pyndiah - Chief Financial Officer Operator Good day and thank you for standing by. Welcome to the C3is Third Quarter 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. Please be advised that this conference is being recorded. I would now like to hand the conference over to your speaker today Dr. Diamantis Andriotis, ...
Brady (BRC) - 2025 Q1 - Earnings Call Transcript
2024-11-18 17:23
Brady Corporation (NYSE:BRC) Q1 2025 Earnings Conference Call November 18, 2024 10:30 AM ET Company Participants Ann Thornton - Chief Financial Officer Russell Shaller - President & Chief Executive Officer Conference Call Participants Steve Ferazani - Sidoti Keith Housum - Northcoast Research Operator Good day, and thank you for standing by. Welcome to the 2025 First Quarter Brady Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation ...
TEL(TOELY) - 2025 Q2 - Earnings Call Transcript
2024-11-18 13:07
Tokyo Electron Limited (OTCPK:TOELY) Q2 2025 Earnings Conference Call November 12, 2024 2:30 AM ET Company Participants Koichi Yatsuda - Investor Relations Department Toshiki Kawai - Representative Director, President & Chief Executive Officer Hiroshi Kawamoto - Senior Vice President & General Manager, Finance Division Conference Call Participants Atsushi Yoshioka - Nomura Securities Yu Yoshida - CLSA Securities Shuhei Nakamura - Goldman Sachs Japan Kenji Yasui - UBS Securities Tetsuya Wadaki - Morgan Stan ...
Digimarc(DMRC) - 2024 Q3 - Earnings Call Transcript
2024-11-17 18:29
Digimarc Corporation (NASDAQ:DMRC) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants George Karamanos - Chief Legal Officer Riley McCormack - CEO Charles Beck - CFO Conference Call Participants Joshua Reilly - Needham Jeffrey Van Rhee - Craig-Hallum Robin Knipp - Janney Montgomery Scott Jeff Bernstein - Silverberg Bernstein Matthew Collard - PCB Advisory Operator Greetings, and welcome to the Digimarc Corporation Third Quarter 2024 Earnings Conference Call. At this time, all ...
IRIDEX (IRIX) - 2024 Q3 - Earnings Call Transcript
2024-11-16 20:53
Financial Data and Key Metrics - Total revenue for Q3 2024 was $11.6 million, a 10% decline compared to $12.9 million in Q3 2023 [17] - Gross profit in Q3 2024 was $4.3 million, down from $5.6 million in Q3 2023, with gross margin declining to 37.3% from 43.7% [20] - Operating expenses decreased by $1.1 million to $6.2 million in Q3 2024 compared to $7.3 million in Q3 2023 [21] - Net loss in Q3 2024 was $1.9 million or $0.12 per share, compared to a net loss of $1.8 million or $0.11 per share in Q3 2023 [22] - Cash and cash equivalents totaled $3.9 million as of September 28, 2024, including $3.4 million from a convertible note offering [23] Business Line Data and Key Metrics - Cyclo G6 product family revenue was $3.1 million in Q3 2024, a 3% increase compared to Q3 2023 [17] - 13,600 Cyclo G6 probes were sold in Q3 2024, a 10% sequential decline from Q2 2024 [18] - Retina segment revenue was $6.5 million in Q3 2024, down 18% compared to Q3 2023 [19] - Other revenue, including royalties and services, was $2 million in Q3 2024, up from $1.9 million in Q3 2023 [19] Market Data and Key Metrics - The company experienced shipment delays in certain regions due to regulatory hurdles, which are expected to be resolved in Q4 2024 [12] - The glaucoma products family showed increasing momentum, with aggregate glaucoma probe and console sales up compared to the prior year [13] Company Strategy and Industry Competition - The company is actively discussing potential transactions with multiple entities, with an announcement possible before the end of 2024 [7] - Cost-cutting measures are being implemented to align expenses with operating cash flows, aiming for EBITDA breakeven or better in Q4 2024 [8][29] - The company is accelerating engagement with global contract manufacturing partners to improve gross margins through increased outsourcing [29] - The revised LCD reimbursement change for glaucoma, effective November 17, 2024, is expected to increase physician adoption of IRIDEX glaucoma products [31][32] Management Commentary on Operating Environment and Future Outlook - The company expects Q4 2024 to be EBITDA positive, driven by seasonal strength and cost optimization efforts [8][24] - Management believes the new LCD reimbursement landscape will significantly benefit IRIDEX by restricting MIGS device usage and increasing adoption of IRIDEX glaucoma products [32] - The company is focusing on competitive advantages and high-return opportunities as it reduces aggressive spending [30] Other Important Information - The company introduced the new I-5 laser platform at the American Academy of Ophthalmology meeting, generating promising leads [14] - The strategic review process has been accelerated, with strong interest expressed by third parties in IRIDEX's global brand and products [7] Q&A Session - No Q&A session was conducted during the call [5][34]
Research Solutions(RSSS) - 2025 Q1 - Earnings Call Transcript
2024-11-16 14:32
Research Solutions, Inc. (NASDAQ:RSSS) Q1 2025 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants Steven Hooser - IR Roy Olivier - President and CEO William Nurthen - CFO Conference Call Participants Richard Baldry - ROTH Capital Jacob Stephan - Lake Street Derek Greenberg - Maxim Group Avram Fisher - Long Cast Advisers Operator Good afternoon, everyone. Welcome to the Research Solutions, Inc. First Quarter Fiscal 2025 Earnings Conference Call. At this time all participants are in a ...
Airgain(AIRG) - 2024 Q3 - Earnings Call Transcript
2024-11-16 02:49
Airgain, Inc. (NASDAQ:AIRG) Q3 2024 Earnings Conference Call November 12, 2024 5:00 PM ET Company Participants Jacob Suen - President and Chief Executive Officer Michael Elbaz - Chief Financial Officer Conference Call Participants Anthony Stoss - Craig-Hallum Capital Group LLC Tim Savageaux - Northland Capital Markets Scott Searle - ROTH Capital Partners Operator Good afternoon. Welcome to Airgain's Third Quarter 2024 Earnings Conference Call. My name is Sherry, and I will be your operator for today's call. ...
Nauticus Robotics(KITT) - 2024 Q3 - Earnings Call Transcript
2024-11-16 02:47
Financial Data and Key Metrics - Revenue for Q3 2024 was $0.4 million, down $0.1 million from Q2 2024 and $1.2 million from the same period last year [23] - Operating expenses for Q3 2024 were $5.9 million, a $3.9 million improvement from Q3 2023 and a $0.6 million sequential improvement [23] - G&A costs for Q3 2024 were $2.8 million, a $3.9 million improvement compared to Q3 2023 and a $0.4 million sequential improvement [23] - Net loss for Q3 2024 was $11.4 million, a $6.3 million reduction from Q3 2023 and a $6 million increase sequentially [24] - Adjusted net loss for Q3 2024 was $11.4 million compared to $9 million for Q2 2024 and $8.1 million in Q3 2023 [24] - Cash at the end of Q3 2024 was $2.9 million compared to $0.7 million at the end of 2023 [25] Business Line Data and Key Metrics - The Aquanaut vehicle successfully completed its first commercial project in Q3 2024, marking a significant milestone for the company [8][12] - The Aquanaut vehicle provided high-quality data on subsea assets at depths up to 1,000 meters, exceeding customer expectations [13] - The company is working on technical modifications to allow year-round operations in the Gulf of Mexico and is exploring opportunities in South America to mitigate seasonality [10][14] - The second Aquanaut vehicle is expected to complete factory acceptance testing in Q4 2024 and be available for commercial service in Q1 2025 [15] - The ToolKITT software platform performed reliably during operations in the Gulf of Mexico, with a commercial release planned for 2025 [18] Market Data and Key Metrics - The company is focused on building a pipeline for the 2025 Gulf season and is actively working to eliminate seasonality in its business [10] - Customers are expanding their scope of work to include the unique capabilities of the Aquanaut vehicle, leading to commercial discussions for the 2025 season [10] - The company is in discussions with South American customers to mitigate Northern Hemisphere seasonality [10] Company Strategy and Industry Competition - The company is focused on leveraging the success of its first commercial projects to create a business backlog for 2025, consisting of both commercial and defense work [8] - The company is working on developing technology that provides an attractive return on investment to shareholders and customers [15] - The company's deepwater autonomous software capabilities surpass those of competitors, paving the way for commercial licenses in 2025 [29] Management Commentary on Operating Environment and Future Outlook - The company is confident that the steps being taken will allow it to regain compliance with NASDAQ's listing requirements by the end of 2024 [21] - The company is focused on securing the cash needed through the end of 2025 as it ramps up commercialization [22] - The company is negotiating day rate contracts that could surpass the total revenue produced in Q3 2024 in a single week [28] Other Important Information - The company completed a 36:1 reverse split on July 22, 2024, and all references to equity and related items are stated on a post-split basis [21] - The company has entered into an agreement with investors to exchange $27 million of principal, $3 million of interest, and $3 million of additional liabilities into preferred convertible stock [21] - The company closed $1.1 million of funding as the first tranche of up to $21.1 million available through a new convertible debenture [22] Summary of Q&A Session - No questions were asked during the Q&A session [30][32]